German medtech startup Clinomic has raised a €23 million financing round co-led by DeepTech & Climate Fonds (DTCF) and a private family office.
Founded in 2019 by intensive care physicians from RWTH Aachen University Hospital, Clinomic developed Mona, an integrated platform designed to streamline intensive care workflows.
Mona records, organises, analyses, and visualises patient and operational data, providing healthcare professionals with real-time insights to enhance decision-making—transforming intensive care to meet both human and technological standards for patients and medical workers.
Dr Arne Peine and Dr Lukas Martin, both Medical Doctors and co-founders, explain:
“As medical doctors working on the ICU, we experience it every day: Data density in high-acuity settings is increasing, leaving us less and less time for the patient.
We need revolutionary new approaches to deliver optimal patient care. Good future care will only be possible if we close existing digitisation gaps and consolidate all relevant data in one place. That’s why we’re building the ‘iPhone for the ICU’.”
Günther Bogenrieder, Investment Manager at DTCF, adds:
“From our very first conversations, we saw how Clinomic is using AI to solve critical healthcare challenges with real, measurable impact. Georg, Arne, Lukas, and their exceptional team are redefining intensive care.
The Mona platform is significantly improving quality of patient care, while reducing healthcare costs by making all relevant data accessible in one platform and thus optimizing clinical and administrative workflows. These results prove that Clinomic is setting a new global standard for digital intensive care.”
Looking ahead, Clinomic’s multi-revenue model – integrating hardware, software, and data services into the “iPhone for the ICU“ – fuels strong retention and scalability.
By expanding Mona’s capabilities into all areas of high acuity care and launching its Health Data Lake to securely aggregate and analyze Intensive Care Medicine, Clinomic will enable seamless interoperability across healthcare systems.
Already partnering with some of Europe’s largest hospitals, the company is striving to accelerate its footprint, delivering AI-driven benefits to large hospital chains, public and university hospitals, and regional facilities internationally.
The funds will be used to expand the company’s presence in global markets and further develop its AI-powered healthcare solutions.
Lead image: Clinomic. Photo: uncredited.
Would you like to write the first comment?
Login to post comments